Moderna Inc reported $13.43B in Current Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acadia Pharmaceuticals ACAD:US USD 507.94M 13.62M
Acorda Therapeutics ACOR:US USD 82.12M 10.42M
Agios Pharmaceuticals AGIO:US USD 832.77M 47.84M
Alnylam Pharmaceuticals ALNY:US USD 2.69B 1.4M
Amgen AMGN:US USD 22.19B 1.88B
Arrowhead Research ARWR:US USD 575M 169.7M
Biogen BIIB:US USD 9.79B 25.4M
Biomarin Pharmaceutical BMRN:US USD 2.75B 68.76M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Esperion Therapeutics ESPR:US USD 246.68M 15.1M
Gilead Sciences GILD:US USD 15.23B 1.67B
GlaxoSmithKline GSK:LN GBP 20.77B 520M
Intercept Pharmaceuticals ICPT:US USD 540.13M 5.24M
Mirati Therapeutics MRTX:US USD 1.11B 116.82M
Puma Biotechnology PBYI:US USD 134.28M 11.93M
Regeneron Pharmaceuticals REGN:US USD 22.06B 6.64B
Sangamo Biosciences SGMO:US USD 300.33M 36.29M
Sarepta Therapeutics SRPT:US USD 2.56B 68.07M
Seattle Genetics SGEN:US USD 2.8B 42.91M
Ultragenyx Pharmaceutical RARE:US USD 883.9M 128.77M
United Therapeutics UTHR:US USD 3.38B 323.9M
Vertex Pharmaceuticals VRTX:US USD 12.68B 410.3M
YTE INCY:US USD 4.09B 271.74M